Rivervest Venture Management LLC

Investment Portfolio & 13F Holdings Analysis

About

Type: FundHoldings: 3Value: $6.8BLatest: 2024Q3

RiverVest Venture Management LLC is an institutional investment manager that filed its latest Form 13F for 2024Q3, reporting 3 holdings worth $6.8 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "SPRB",
  null,
  "XLO"
]

Filing Details

13F-HR • 2024-09-30

SEC FilingSEC DataHachi Filing

Report Date: 2024-09-30
Filing Date: 2024-10-30
Total Holdings: 3
Total Value: 6838040
Accession Number: 0001104659-24-112539
Form Type: 13F-HR
CIK: rivervest-venture-management
Manager Name: Rivervest-Venture-Management

Data Enrichment

67% identified

2 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

3 positions • $6.8M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Sort by:

75974E103

Shares:2.5M

Value:$4.3B

% of Portfolio:63003.1% ($4.3B/$6.8M)

SPRUCE BIOSCIENCES, INC.

SPRB|85209E109

Shares:2.9M

Value:$1.4B

% of Portfolio:20392.4% ($1.4B/$6.8M)

Xilio Therapeutics, Inc.

XLO|98422T100

Shares:1.4M

Value:$1.1B

% of Portfolio:16604.5% ($1.1B/$6.8M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip75974E103)✕	2.5M	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$4.3B	63003.1% ($4.3B/$6.8M)	QoQ +12.58% (+$482) YoY-
SPRUCE BIOSCIENCES, INC.(SPRBcusip85209E109)	2.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.4B	20392.4% ($1.4B/$6.8M)	QoQ -8.26% (-$126) YoY-
Xilio Therapeutics, Inc.(XLOcusip98422T100)	1.4M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.1B	16604.5% ($1.1B/$6.8M)	QoQ -16.86% (-$230) YoY-